Ann: Issuance of Convertible Notes & Warrants for up to $46m, page-38

  1. 3,640 Posts.
    lightbulb Created with Sketch. 1039
    This is funny, shorters and downrampers were shown m***le finger just before Christmas, now enjoy your "Turkey" santa is on his way with margin call..

    Just some positivity

    Positive clinical results will drive share price in s2025 and may facilitate warrant exercises this will potentially unlock an additional AUD 26 million just imagine the expanded clinical trials will show Imugene’s pipeline credibility With a 25% premium conversion price for notes and 130% premium for warrants

    all those jumping up and down on ownership, please the ownership capped of 9.9% so just stop spreading false news.. as the success of the funding is closely tied to the clinical pipeline's progress and funding is targeted towards 2025, this means IMU is planning big in 2025 this shows confidence..
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.3¢
Change
-0.002(10.7%)
Mkt cap ! $93.33M
Open High Low Value Volume
1.3¢ 1.3¢ 1.2¢ $144.1K 11.58M

Buyers (Bids)

No. Vol. Price($)
43 12868726 1.2¢
 

Sellers (Offers)

Price($) Vol. No.
1.3¢ 3376989 18
View Market Depth
Last trade - 11.59am 23/06/2025 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.